Patent cliffs & loss of exclusivity
Intersect ENT, founded in 2003 and based in Menlo Park, California, developed steroid-eluting sinus implants including PROPEL and SINUVA. Medtronic acquired the company in May 2022 and incorporated its products and employees into its ENT business.
| AngelList URL | https://angel.co/intersect-ent |
|---|---|
| Legal Name | Intersect ENT, Inc. |
| Company Operating Status | Acquired |
| Crunchbase URL | https://www.crunchbase.com/organization/intersect |
| Facebook URL | https://www.facebook.com/intersectent/ |
| Full Address | 1555 Adams Drive Menlo Park, CA 94025 |
| LinkedIn URL | https://www.linkedin.com/company/intersect-ent |
| Pitchbook URL | https://pitchbook.com/profiles/company/50950-81 |
Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.